Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

AI detects subtle changes in images over time.

Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings

The Learning-based Inference of Longitudinal imAge Changes, or LILAC, system harnesses machine learning to review medical images that have been collected over a prolonged period.

Good Pixel Smartwatch Loss of Pulse.

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

Popular TAVR valves linked to comparable long-term outcomes

Second-generation TAVR valves from Medtronic, Edwards Lifesciences and Boston Scientific are all associated with similar seven-year outcomes, according to a new retrospective study out of Italy. 

Walgreens resolves $595M lawsuit over COVID testing

The dispute was with Everly Health, a telemedicine provider contracted to fulfill orders for COVID-19 tests during the pandemic. Walgreens was accused of violating provisions of a service agreement. 

Proteins in tardigrades could help prevent radiation-induced side effects.

Tiny 'water bears' may hold key to reducing radiation-induced side effects

These animals are virtually indestructible and have long outlived the dinosaurs due to their ability to withstand extreme cold, heat, natural disasters and even cosmic radiation.

Kestra Medical Technologies

Wearable heart device company to go public, raise up to $155M

Kestra Medical Technologies, known for its wearable heart monitors and defibrillators, intends to sell 10 million common shares priced somewhere between $14 and $16 per share. 

Prevail DCB Medtronic

Medtronic enrolls first patient in new coronary DCB trial—data could lead to FDA approval

The paclitaxel-coated device, already approved in Europe and other parts of the world, will be tested on more than 1,200 patients for a new international trial. If the study is a success, Medtronic hopes to gain regulatory approval in the United States and Japan. 

Newsweek ranked the 50 best heart hospitals in the world

Know your options: What cardiologists recommend when alternative access is required for TAVR

Transfemoral TAVR is not always a viable option. In those instances, the two most effective alternatives are transcarotid access and transcaval access, according to a new SCAI expert consensus statement.